Neuroalojen ja kuntoutuksen vastuualue

Julkaisut 2011
Publications 2011

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Ainiala H. Neuropsychiatric involvement in systemic lupus erythematosus.
2 Aronica E, Crino PB. Inflammmation in epilepsy: clinical observations.
3 Dubourg O et al. A novel MYH7 mutation occurring independently in French and Norwegian Laing distal myopathy families and de novo in one Finnish patient.
4 Duff RM et al. Mutations in the N-terminal actin-binding domain of filamin C cause a distal myopathy.
5 Elovaara I. Early treatment in multiple sclerosis.
6 Elovaara I et al. Intravenous immunoglobulins are a therapeutic option in the treatment of multiple sclerosis relapse.
7 Fugier C et al. Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy.
8 Griggs RC, Udd BA. Markesbery Disease: Autosomal Dominant Late-Onset Distal Myopathy: From Phenotype to ZASP Gene Identification.
9 Hackman P et al. Four new Finnish families with LGMD1D; refinement of the clinical phenotype and the linked 7q36 locus.
10 Hagman S. Inflammatory biomarkers in multiple sclerosis.
11 Hagman S et al. Disease-associated inflammatory biomarker profiles in blood in different subtypes of multiple sclerosis: prospective clinical and MRI follow-up study.
12 Hilbert P et al. Normal muscle MRI does not preclude increased connective tissue in muscle of recessive myotonia congenita.
13 International MULTIPLE Sclerosis Genetics Consortium. The genetic association of variants in CD6, TNFRSF1A and IRF8 to multiple sclerosis: a multicenter case-control study.
14 Iverson GL et al. To exclude or not to exclude: white matter hyperintensities in diffusion tensor imaging research.
15 Karinkanta S. To keep fit and function.
16 Kok EH et al. CRP gene variation affects early development of Alzheimer's disease-related plaques.
17 Kok EH et al. CLU, CR1 and PICALM genes associate with Alzheimer's-related senile plaques.
18 Koskinen MJ et al. Intraepidermal nerve fibre density in cancer patients receiving adjuvant chemotherapy.
19 Laihosalo M et al. Thrombolytic therapy and visuoperceptual functions in right hemisphere infarct patients.
20 Lasry-levy E et al. Neuropathic pain and psychological morbidity in patients with treated leprosy: a cross-sectional prevalence study in Mumbai.
21 Lehtimäki KA et al. The serum level of interleukin-6 in patients with intellectual disability and refractory epilepsy.
22 Lehtimäki KA et al. Cardiolipin and ß(2)-Glycoprotein I antibodies associate with cognitive impairment and seizure frequency in developmental disorders.
23 Liimatainen S et al. Lievät aivovammat päivystyslääketieteessä.
24 Liimatainen S et al. Nonkonvulsiivisen status epilepticuksen hoito.
25 Malmivaara K et al. Cost-effectiveness of decompressive craniectomy in non-traumatic neurological emergencies.
26 Meretoja A et al. Direct Costs of Patients With Stroke Can Be Continuously Monitored on a National Level: Performance, Effectiveness, and Costs of Treatment Episodes in Stroke (PERFECT Stroke) Database in Finland.
27 Meretoja A et al. Trends in treatment and outcome of stroke patients in Finland from 1999 to 2007. PERFECT Stroke, a nationwide register study.
28 Mustila T et al. Pediatric Cushing´s disease due to pituitary hyperplasia.
29 Numminen HJ. The incidence of traumatic brain injury in an adult population - how to classify mild cases?
30 Palmio J. Heikkenevät alaraajavoimat - taustalla neurologinen syy?
31 Palmio J et al. Distinct distal myopathy phenotype caused by VCP gene mutation in a Finnish family.
32 Paltamaa J et al. Hyvän kuntoutuskäytännön perusta - Käytännön ja tutkimustiedon analyysistä suosituksiin vaikeavammaisten kuntoutuksen kehittämishankkeessa.
33 Pynnönen L et al. Therapeutic hypothermia after cardiac arrest - cerebral perfusion and metabolism during upper and lower threshold normocapnia.
34 Pyysalo LM et al. Long-term MRI findings of patients with embolized cerebral aneurysms.
35 Pyysalo LM et al. Long term outcome after subarachnoid haemorrhage of unknown aetiology.
36 Pöllänen P, Tammela T. Andrologiset lääkkeet.
37 Rosti-Otajärvi EM, Hämäläinen PI. Neuropsychological rehabilitation for multiple sclerosis.
38 Sairanen T et al. Two years of Finnish Telestroke: thrombolysis at spokes equal to that at the hub.
39 Salenius JP et al. Valtimoperäiset ääreisverenkierron häiriöt.
40 Sikiö M et al. Parkinson's disease: interhemispheric textural differences in MR images.
41 Sillanpaa N et al. CT perfusion ASPECTS in the evaluation of acute ischemic stroke: Thrombolytic therapy perspective.
42 Sumelahti ML et al. Prescription patterns in preventive and abortive migraine medication.
43 Sundberg M et al. Markers of pluripotency and differentiation in human neural precursor cells derived from embryonic stem cells and CNS tissue.
44 Suominen T et al. Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.
45 Thesleff T et al. Cranioplasty with adipose-derived stem cells and biomaterial: a novel method for cranial reconstruction.
46 Turunen U, Jussila A. Krooniset tulehdukselliset suolistosairaudet.
47 Udd B et al. Myotonic dystrophy type 2 (DM2) and related disorders report of the 180th ENMC workshop including guidelines on diagnostics and management 3-5 December 2010, Naarden, The Netherlands.
48 Vuola J et al. Microvascular free flap reconstruction of skull base penetrating tumors.
Julkaisutietokanta 21.9.2012 Publications Data Base 21.9.2012